Health Care & Life Sciences » Pharmaceuticals | Concert Pharmaceuticals Inc.

Concert Pharmaceuticals Inc.

Concert Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
23.42 M
Public Float
22.11 M
Concert Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.13
Market Cap
$290.07 M
Shares Outstanding
23.8 M
Public Float
19.43 M

Profile

Address
99 Hayden Avenue
Lexington Massachusetts 02421
United States
Employees -
Website http://www.concertpharma.com
Updated 07/08/2019
Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H.

Financials

View All

Roger D. Tung
President, Chief Executive Officer & Director
Rich H. Aldrich
Chairman